No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Aged
-
Cladribine / administration & dosage
-
Cladribine / pharmacology
-
Cladribine / therapeutic use*
-
Combined Modality Therapy
-
Disease Progression
-
Drug Evaluation
-
Female
-
Histiocytosis, Langerhans-Cell / diagnostic imaging
-
Histiocytosis, Langerhans-Cell / drug therapy*
-
Histiocytosis, Langerhans-Cell / physiopathology
-
Histiocytosis, Langerhans-Cell / therapy
-
Humans
-
Kaplan-Meier Estimate
-
MAP Kinase Signaling System / drug effects
-
Magnetic Resonance Imaging
-
Male
-
Middle Aged
-
Mutation, Missense
-
Point Mutation
-
Positron Emission Tomography Computed Tomography
-
Progression-Free Survival
-
Proto-Oncogene Proteins B-raf / genetics
-
Pulmonary Diffusing Capacity / drug effects
-
Retrospective Studies
-
Treatment Outcome
-
Young Adult
Substances
-
Cladribine
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf